SCHEMBL10012059

SCHEMBL10012059

CC(C)(C#N)COC(=O)CCC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.38
KDM6B O15054 1/20 0.38
KDM5C P41229 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
LMNA P02545 3/20 0.36
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SLC15A2 Q16348 1/20 0.32
TSHR P16473 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA1A P35348 1/20 0.31
PAM P19021 2/20 0.31
MAPT P10636 1/20 0.31
BLM P54132 1/20 0.31
VCAM1 P19320 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10012056 0.92 ADRA2A (0.35) ALDH1A1TSHRADRA2AADRA1AMAPT
SCHEMBL10012818 0.89 TSHR (0.41) LMNAALDH1A1TSHRPAM
SCHEMBL10010090 0.89 TSHR (0.46) LMNAALDH1A1TSHRPAMVCAM1
SCHEMBL10012611 0.88 PAM (0.42) LMNAALDH1A1TSHRPAM
SCHEMBL10012816 0.85 DGKA (0.39) LMNAALDH1A1TSHRPAMMAPT
SCHEMBL10010089 0.85 TSHR (0.38) LMNAALDH1A1TSHRPAMMAPT
SCHEMBL10012609 0.83 DGKA (0.42) LMNAALDH1A1TSHRPAMMAPT
SCHEMBL10011912 0.82 ADRA2A (0.37) EGLN1KDM6BKDM5CPHF8KDM2A
SCHEMBL10012734 0.81 EGLN1 (0.38) EGLN1KDM6BKDM5CPHF8KDM2A
SCHEMBL28602342 0.80 DGKA (0.44) LMNAALDH1A1TSHRPAMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 EGLN1 2425/4885KDM6B 2957/4885KDM5C 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.